The Vein Institute was founded to care for patients with varicose vein disease. Using the latest and most innovative treatments from the USA and Europe means that The Vein Institute is able to offer surgery free treatments for patients with medical problems. As part of our commitment to treating varicose vein disease multiple clinics around Australia have been established.
Our philosophy is to offer walk in walk out treatments which are safer than traditional surgery, without the need for hospital admission or general anaesthetic. We place a strong emphasis on providing a warm relaxing environment for patients in addition to offering convenient hours, including weekend and after-hours treatment options.
Dr Zil Yassine
Dr Zil Yassine (BA MBBS Uni. NSW, MA Harvard, Fellow (College of Phlebology UK) specialises in the non surgical treatment of varicose veins. He completed training as a Specialist General Practitioner (FRACGP 2014) in Sydney before successfully completing the American Board of Venous and Lymphatic Medicine examinations that same year. He has been a doctor for over 10 years and has performed thousands of venous interventions and gives talks on vein treatments at vascular surgeon conferences. Dr Yassine also holds the following degrees: Bachelor of Arts, Bachelor of Medicine, Bachelor of Science, Bachelor of Surgery (UNSW), Masters of Arts (Harvard University), Diploma of Diagnostic Ultrasound in Phlebology (ACP).
- Australian and New Zealand Society of Phlebology
- European Venous Forum
- American College of Phlebology
- College of Phlebology (UK)
Dr Jane Li
Dr Christine Chan
Christine has a special interest in Endovascular Surgery, Interventional Oncology, Interventional Radiology treatment for Women and Breast Imaging. Christine performs a wide range of venous procedures including treatment of Pelvic Congestion Syndrome, Varicocele, Varicose Veins and Vascular Malformations.
Christine is a clinical lecturer at the University of Sydney as well as University of New South Wales and an appointed International Medical Graduate assessor for The Royal Australian and New Zealand College of Radiologists. Christine is also currently the Director of Training at the Royal Prince Alfred Hospital.
Dr Cosmin Florescu
We are proud to announce our partnership with Dr Cosmin Florescu, Interventional Radiologist and member of the European Board of Interventional Radiology (EBIR). Cosmin graduated from the University of Melbourne in 2004 and undertook Fellowship training in Radiology through Monash Health. He currently holds public appointments as an Interventional Radiologist at both St. Vincent’s Hospital and Monash Health.
In addition to the innovative approach of arterial embolisation for benign prostatic enlargement, Cosmin offers a variety of radiological procedures including varicocele embolisation, nephrostomy tube management, radiofrequency ablation and renal mass biopsy.
Dr Radha K Popuri
Dr Jonathan Robertson
Dr Robertson is an Interventional Radiologist and endovascular specialist. He trained in Radiology at the Royal Brisbane and Women’s Hospital and undertook further subspecialist training in Interventional Radiology at Singapore General Hospital.
Jonathan is a member of the Interventional Radiology Society of Australasia and the Cardiovascular Interventional Radiology Society of Europe and is certified with the European Board of Interventional Radiology (EBIR).
Jonathan has worked as an Interventional Radiologist at Royal Brisbane and Women’s Hospital and Sunshine Coast University Hospital before starting in private practice as Director of Sunshine Coast Endovascular. Jonathan is a Senior Lecturer at the University of Queensland and is actively involved in registrar training both on the Sunshine Coast and in Brisbane.
Jonathan’s interests include all aspects of Interventional Radiology and Endovascular Surgery, with particular emphasis on treatment of varicose veins and deep vein thrombosis, uterine fibroid embolization, prostate artery embolization, testicular varicocele embolization and liver directed therapies for hepatocellular carcinoma and hepatic metastatic disease.